{'fraction_non_alphanumeric': 0.024229074889867842, 'fraction_numerical': 0.01762114537444934, 'mean_word_length': 5.232876712328767, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An Update on Eyelid Sebaceous Cell Carcinoma

Eyelid sebaceous carcinoma (SC) is a highly malignant and potentially lethal tumor, which was initially described by Allaire in 1891.1,2 It is usually invasive in the periorbital region, and it can also metastasize to regional lymph nodes and distant organs.3,4 This tumor often masquerades as a benign or inflammatory lesion, resulting in delayed diagnosis, which can lead to higher morbidity and mortality.